Loading...
•
Sep 30, 2024
XpresSpa Q3 2024 Earnings Report
XWELL's third quarter performance in 2024 was marked by growth and productivity initiatives.
Key Takeaways
XWELL, Inc. reported a revenue of $8.4 million for the third quarter of 2024, compared to $7.5 million for the 2023 third quarter. The operating loss was approximately $4.8 million, compared with an operating loss of approximately $12.1 million for the 2023 third quarter. Net loss attributable to XWELL was approximately $4.8 million, compared to approximately $11.5 million for the 2023 third quarter.
Total revenue for the third quarter ended September 30, 2024, was $8.4 million, compared to $7.5 million for the 2023 third quarter.
Revenue for the 2024 third quarter primarily consisted of approximately $4.9 million from XpresSpa locations and Treat locations and approximately $3.1 million from XpresTest, which includes XWELL’s bio-surveillance partnership and its HyperPointe business.
The operating loss was approximately $4.8 million, compared with an operating loss of approximately $12.1 million for the 2023 third quarter.
As of September 30, 2024, the Company had approximately $4.4 million of cash and cash equivalents and approximately $11.7 million in marketable securities.
Forward Guidance
XWELL believes it's well-positioned for a strong 2025 and remains confident that its consistent strategy execution will benefit its customers, partners, employees, and shareholders.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...